PPV combined with subretinal rt-PA and gas tamponade is effective for SMH (13, 17, 18), while anti-VEGF therapy, widely used for choroidal neovascularization (CNV), addresses SMH's underlying cause (19). Here, VEGFA is linked to choroidal neovascularization.